Treatment Strategies for Refractory Depression
31%
off

Treatment Strategies for Refractory Depression

By (author) 

Free delivery worldwide

Available. Dispatched from the UK in 1 business day
When will my order arrive?

Description

Over the years there have been many published articles and symposia on the diagnosis and treatment of refractory depression, but there have been surprisingly few data. This paucity of data reflects the absence of an effective, sustained research effort on this topic. The authors of Treatment Strategies for Refractory Depression review all available controlled studies as well as the results of open clinical trials to help the clinician answer questions often faced in the clinical setting. Does the treatment fit the illness? Are the patients truly refractory to treatment or simply inadequately treated, and if indeed they appear to be treatment-resistant, resistant to what treatment? Is the methodology appropriately rigorous in studies assessing the effectiveness of alternative treatments in "treatment resistant" depressions? Do factors such as chronicity or personality characteristics predict poor response? Among the many subjects addressed in this volume are lithium augmentation, the use of monoamine oxidase inhibitors, ECT, tricyclic nonresponse, serotonergic agents, thyroid function, chronic depressive disorders, and the effect of Axis II disorders on treatment outcome. Seventeen leading authorities on refractory depression contribute to this volume, the outgrowth of a symposium presented at an annual meeting of the American Psychiatric Association.show more

Product details

  • Paperback | 238 pages
  • 140 x 210 x 12.95mm | 281.23g
  • American Psychiatric Association Publishing
  • American Psychiatric Publishing
  • VA, United States
  • English
  • 1585624462
  • 9781585624461

Flap copy

Over the years there have been many published articles and symposia on the diagnosis and treatment of refractory depression, but there have been surprisingly few data. This paucity of data reflects the absence of an effective, sustained research effort on this topic. The authors of Treatment Strategies for Refractory Depression review all available controlled studies as well as the results of open clinical trials to help the clinician answer questions often faced in the clinical setting. Does the treatment fit the illness? Are the patients truly refractory to treatment or simply inadequately treated, and if indeed they appear to be treatment-resistant, resistant to what treatment? Is the methodology appropriately rigorous in studies assessing the effectiveness of alternative treatments in "treatment resistant" depressions? Do factors such as chronicity or personality characteristics predict poor response? Among the many subjects addressed in this volume are lithium augmentation, the use of monoamine oxidase inhibitors, ECT, tricyclic nonresponse, serotonergic agents, thyroid function, chronic depressive disorders, and the effect of Axis II disorders on treatment outcome. Seventeen leading authorities on refractory depression contribute to this volume, the outgrowth of a symposium presented at an annual meeting of the American Psychiatric Association.show more

About Steven P. Roose

Steven P. Roose, M.D., is Associate Professor of Clinical Psychiatry, College of Physicians and Surgeons, Columbia University; and Research Psychiatrist, New York State Psychiatric Institute. Alexander H. Glassman, M.D., is Professor of Clinical Psychiatry, College of Physicians and Surgeons, Columbia University; and Chief of Clinical Psychopharmacology, New York State Psychiatric Institute.show more

Table of contents

Contributors. Introduction to the progress in psychiatry series. Methodological issues in the diagnosis, treatment, and study of refractory depression. Adequate tricyclic treatment: defining the tricyclic nonresponder. Lithium augmentation in refractory depression. The use of monoamine oxidase inhibitors in refractory depression. Carbamazepine and other antiepileptic drugs in refractory depression. Refractory depression and electroconvulsive therapy. Calcium channel blockers in treatment-resistant bipolar and unipolar affective disorders. Serotonergic agents in the treatment of refractory depression. Thyroid function in refractory depression. Chronic depression versus treatment-refractory depression: evaluation and treatment. Axis II personality disorders and personality features in treatment-resistant and refractory depression. Index.show more